Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway
G Shi, X Li, W Wang, L Hou, L Yin, L Wang - Cell Biochemistry and …, 2024 - Springer
Breast cancer (BC) is a lethal disorder that threatens the life safety of the majority of females
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …
Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway
G Shi, X Li, W Wang, L Hou, L Yin… - Cell biochemistry and … - pubmed.ncbi.nlm.nih.gov
Breast cancer (BC) is a lethal disorder that threatens the life safety of the majority of females
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …
Allicin Overcomes Doxorubicin Resistance of Breast Cancer Cells by Targeting the Nrf2 Pathway.
G Shi, X Li, W Wang, L Hou, L Yin… - Cell Biochemistry and …, 2024 - europepmc.org
Breast cancer (BC) is a lethal disorder that threatens the life safety of the majority of females
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …
globally, with rising morbidity and mortality year by year. Doxorubicin is a cytotoxic …